Martingale Asset Management’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-16,426
| Closed | -$245K | – | 817 |
|
|
2024
Q4 | $245K | Hold |
16,426
| – | – | 0.01% | 719 |
|
|
2024
Q3 | $251K | Buy |
+16,426
| New | +$251K | 0.01% | 735 |
|
|
2024
Q2 | – | Sell |
-19,825
| Closed | -$374K | – | 836 |
|
|
2024
Q1 | $374K | Sell |
19,825
-704
| -3% | -$13.3K | 0.01% | 669 |
|
|
2023
Q4 | $392K | Sell |
20,529
-9
| -0% | -$172 | 0.01% | 657 |
|
|
2023
Q3 | $369K | Sell |
20,538
-506
| -2% | -$9.08K | 0.01% | 653 |
|
|
2023
Q2 | $427K | Sell |
21,044
-2,209
| -9% | -$44.9K | 0.01% | 644 |
|
|
2023
Q1 | $424K | Buy |
+23,253
| New | +$424K | 0.01% | 656 |
|
|
2021
Q4 | – | Sell |
-15,800
| Closed | -$551K | – | 881 |
|
|
2021
Q3 | $551K | Buy |
15,800
+4,100
| +35% | +$143K | 0.01% | 650 |
|
|
2021
Q2 | $322K | Buy |
+11,700
| New | +$322K | ﹤0.01% | 707 |
|
|
2021
Q1 | – | Sell |
-12,453
| Closed | -$324K | – | 902 |
|
|
2020
Q4 | $324K | Sell |
12,453
-49,540
| -80% | -$1.29M | ﹤0.01% | 723 |
|
|
2020
Q3 | $1.06M | Sell |
61,993
-32,400
| -34% | -$556K | 0.01% | 618 |
|
|
2020
Q2 | $2.34M | Buy |
+94,393
| New | +$2.34M | 0.03% | 476 |
|